02 October 2003
GW274150 inhibits nitric oxide production by primary cultures of rat proximal tubular cells
Prabal K. Chatterjee, Espen O. Kvale, Nimesh S.A. Patel, Christoph ThiemermannMed Sci Monit 2003; 9(10): BR357-362 :: ID: 13216
Abstract
Background:Production of nitric oxide (NO) subsequent to expression of inducible NO synthase (iNOS) contributes to the development of ischemic renal injury and inflammation. Here we investigate the effects of GW274150, a potent, long-acting and highly selective inhibitor of iNOS activity, on NO production by primary cultures of rat proximal tubular cells (PTC).Material/Methods:Pure populations of PTC were isolated from the cortex of kidneys obtained from male Wistar rats using a combination of collagenase digestion, sieving and Percoll centrifugation. Confluent PTC cultures were incubated for 1–24 h with MEM, interferon-gamma (IFN-gamma, 100 mcg/ml), bacterial lipopolysaccharide (LPS, 10 mcg/ml) in combination after which NO production was determined. PTC were also incubated with IFN-gamma (100 mcg/ml) and LPS (10 mcg/ml) and increasing concentrations of GW274150 or L-N[sup]6[/sup]-(1-iminoethyl)lysine (L-NIL) (10 nM – 1 mM) for 24 h after which nitrite levels in the incubation medium were measured.Results:IFN-gamma and LPS in combination produced a significant, time-dependent increase in NO production. Both GW274150 and L-NIL produced a significant and concentration-dependent inhibition of NO production. However, GW274150 was markedly more potent (EC[sub]50[/sub] ~ 100 nM) than L-NIL (EC[sub]50[/sub] ~ 10 mcM).Conclusions:GW274150 inhibits NO production by primary cultures of PTCs and may therefore be useful in conditions associated with nitrosative stress of the kidney.
Keywords: Dose-Response Relationship, Drug, Enzyme Inhibitors - pharmacology, Interferon Type II - metabolism, Kidney - metabolism, Kidney Tubules - cytology, Kidney Tubules - drug effects, Kidney Tubules - metabolism, Lipopolysaccharides - metabolism, Lysine - analogs & derivatives, Lysine - metabolism, NG-Nitroarginine Methyl Ester - metabolism, Nitrates - metabolism, Nitric Oxide - metabolism, Nitric Oxide Synthase - antagonists & inhibitors, Nitric Oxide Synthase - metabolism, Nitric Oxide Synthase Type II, Nitrites - metabolism, Nitrogen - metabolism, Sulfides - pharmacology, Time Factors
Editorial
01 April 2025 : Editorial
Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to HumansDOI: 10.12659/MSM.949109
Med Sci Monit 2025; 31:e949109
In Press
Review article
A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitor...Med Sci Monit In Press; DOI: 10.12659/MSM.949300
Clinical Research
Buccal Acupuncture Reduces the Dose of Sufentanil Needed in Laparoscopic Gynecological SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947088
Review article
Global Guidelines and Trends in HPV Vaccination for Cervical Cancer PreventionMed Sci Monit In Press; DOI: 10.12659/MSM.947173
Clinical Research
Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelome...Med Sci Monit In Press; DOI: 10.12659/MSM.947873
Most Viewed Current Articles
17 Jan 2024 : Review article 7,932,897
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,919
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 29,882
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 23,844
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912